|
Collaboration among health care organizations offers access to larger patient populations for study and the opportunity to share expertise and resources. DACP has formed many national and international partnerships for collaborative work on both research and policy issues.
DACP/Harvard Pilgrim leads the HMO Research Network Center for Education and Research on Therapeutics (CERTs), one of 11 centers created by Congressional mandate to serve as a trusted national resource regarding treatments with drugs, biological agents and devices. The CERTs are administered by the U.S. Agency for Healthcare Research and Quality in conjunction with the Food and Drug Administration. They study a wide array of topics, ranging from drug safety and effectiveness to improving the ways drugs are used. Recent studies have evaluated trends in the use of prescription drugs during pregnancy and ways to improve long-term adherence to medical therapy.
DACP is a member of the HMO Cancer Research Network, which includes 12 health care organizations with a combined population of over ten million enrollees. This National Cancer Institute-funded group performs collaborative research on cancer detection, prevention and treatment. They conduct studies on many cancer-related topics, such as smoking cessation, mammography screening and the quality of life among cancer survivors.
DACP also has a thriving international program – its Drug Policy Research Group, in association with Boston University’s Center for International Health and Development, has been designated a World Health Organization (WHO) Collaborating Center in Pharmaceutical Policy. DACP faculty work closely with WHO on issues related to improving access to medicines in developing countries. This work is crucial, since more than one-third of the world’s population currently lacks access to high-quality, affordable medicines.
Dana Farber/Harvard Cancer Center Community Practice Core - Linking investigators to real-life clinical settings for cancer research
Larissa Nekhlyudov
HMO Research Network Center for Education and Research in Therapeutics (CERT) -
Richard Platt
The HMO Cancer Research Network - Using delivery systems to conduct population-based research on cancer
Medicines and Insurance Coverage (MedIC) Initiative - improving access to medications for poor populations around the world.
Dennis Ross-Degnan
WHO Collaborating Center for Pharmaceutical Policy: Improving pharmaceutical policy in developing nations
Dennis-Ross Degnan
National Bioterrorism Syndromic Surveillance Demonstration Program:
Richard Platt
|
